{"name":"Taris Biomedical LLC","slug":"taris-biomedical-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNNFVBb3lfZzZNa0toR21ONGtMeGdqU216blZsbl9qUzI1MTN4Y3pxSzFSSlBpSllKX1cyZ2hVajhEUnlWcmZsczFOMEpoZ0JMcGVCczhPNmFwTWhyTkc5MzdSSzMzMktETXRDTkF6YXNWUXlIZTUxdWh6MHhCdURKUTQ1ZGNRTnVBaDBrcEJWM3dsNkZJRDFhLVNwZDVZRWIweDFBcV9OeThkcUJhdEszMHc5eTByZ2EyWUlTVVV6eUs?oc=5","date":"2025-09-10","type":"regulatory","source":"Fierce Pharma","summary":"J&J's 'practice-changing' bladder cancer therapy Inlexzo lands FDA nod - Fierce Pharma","headline":"J&J's 'practice-changing' bladder cancer therapy Inlexzo lands FDA nod","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQTFhKSXZ4N3VkdHZtZmV3S1dBOFFGajFBc0xzb0ZLcnhEc3NRQ21NTDl4YjNQR3hlYmlZLTNENTBTeWdEamVMblExUkJwZV9Yam9IWU5rbmpYbVNnMDExVnc1b2VVeVF4MkFRNDI1TVBlQUxwNm5UUXh5WmxSTG5ESjhReEZLWFhkWVVJU1BDZ25uTU1zX25Tdm1HMVhUT0Fm?oc=5","date":"2025-09-09","type":"regulatory","source":"BioWorld News","summary":"J&J wins US FDA approval of Inlexzo for bladder cancer - BioWorld News","headline":"J&J wins US FDA approval of Inlexzo for bladder cancer","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOX3V6SzFLRWl2RFlMcXJWRGszbUE3Snd3cFlRNUNmclFVYkM3UElvdDZhYkhXR1M0TFNoTE9mY1lOaWJkcy1vT3lhVzQ0Vkk3ZXBsX214clhWZUpnNXdIcU5EcmRGYlVzZ3BVcmZJOUo0NlMtbVpyUVBvdFUyWjlBbmJHMHFfX1JEcHhibmxtazg1anRVeTEwSy1qUlkySVVZNmRhMVlRMExzZ1NUTGFVVDhfOA?oc=5","date":"2024-10-08","type":"trial","source":"Fierce Biotech","summary":"J&J stops phase 3 trial of $5B bladder cancer prospect after interim review flop - Fierce Biotech","headline":"J&J stops phase 3 trial of $5B bladder cancer prospect after interim review flop","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPTEt0SmtnRXFaanpCOVVpU3NBdFJDQUQwRk1IekdhMGZ6V0laNVRXVURKWHBLdXluZUZCOGxuNEw1WkJWRlJTREFFVDNLS01FekFLMFVuM0xWc0dtMWR0ZFEwUWNMME5KQVYtWjV3ZWl5YmxCaGZVSDY5Z09UdEx5V2t4SFpVaVAxaTdONi1meEg?oc=5","date":"2020-01-02","type":"deal","source":"Contract Pharma","summary":"Johnson & Johnson Acquires TARIS Biomedical - Contract Pharma","headline":"Johnson & Johnson Acquires TARIS Biomedical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNX0lXbHZZazl2U0pPSVFveFZLdGV5Wk55b0FZMEZobXFmbkoyMEhCNHdwT0g5bkZ4eC00SDE5M2Y2aTN6S2syaGVtMXpjUXF0OEtWYzhEOUpiTDBrSGlMak1QcS1yaHI4Q19qS2VjeDVGclA3elZzUkdMS1FXQ2RXNVZOVDdRNW5qbERnaUNPME40X2pmTHBEOEQyVzNCVzh4N1ZkWkVaX0J4RGla?oc=5","date":"2019-12-20","type":"deal","source":"NAI500","summary":"Healthcare Roundup – J&J acquires Taris Biomedical, Gilead’s Vosevi OK’d in China - NAI500","headline":"Healthcare Roundup – J&J acquires Taris Biomedical, Gilead’s Vosevi OK’d in China - NAI500","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNekZ2aVN0UVpzUDNUN1o0WUhTOTJKZENPdE1tdjU4dnM2bjAtSVc5SkN3Q0x0Wkc2VVNyOW03MDNJZFdQc0hFV1lTTnVGN3ZOUkZnYnFHd1VBbE1UeTA2VmlrZW4yX1VSUEpCeWVkNDJqSDViaGkxX0NZb1g4Ymxhd2NKRDJtdkxLbnNjbFdxcXpEQUEwbHJZaFlfUQ?oc=5","date":"2017-01-06","type":"trial","source":"MassDevice","summary":"Taris Biomedical closes enrollment in phase Ib trial for drug-device combo - MassDevice","headline":"Taris Biomedical closes enrollment in phase Ib trial for drug-device combo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQQWhCTzk1aEYyTDJNbVJoZ01mejMwMGVYQWZpcGxwb3dkWDRVTl81T19idnhNa29pcHZTOUlnMG9QRVMwRlJHSW5rNW1BczFaWEVtYUhLbnJkbXdLdXV2bjRhbDNxMi0tWkJDei1LZ1lDeTN6dk9FOVR6bEI1UllhdkY2a3J0R2ZhV3dMZG41RF9RME5IZno4dTRRczBmLTFFWWhiUzQ5X29yV0FqYlNEQjJiZGhNTENYeWxtYUQzVnp1TG1SM1JmbmlMTk1rNi04UlE?oc=5","date":"2015-10-27","type":"deal","source":"BioSpace","summary":"After Last Year’s $587.5 Million Deal With Allergan, TARIS Biomedical Relaunches With $32 Million Investment Round - BioSpace","headline":"After Last Year’s $587.5 Million Deal With Allergan, TARIS Biomedical Relaunches With $32 Million Investment Round","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}